WCN26-3099 Normal Protein Catabolic Rate (nPCR) as a Predictor of Weight Loss in Hemodialysis Patients Treated with Tirzepatide

Read full text Summarise with VIRAT
Authors: Jyunichiro Hashiguchi, Kenji Sawase, Akihiro Maekawa, Koutaro Shimoyama
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Tirzepatide, a dual GLP-1/GIP receptor agonist, has demonstrated substantial weight-reducing effects in patients with type 2 diabetes mellitus (T2DM). However, its impact in maintenance hemodialysis (HD) patients remains under-explored, and spontaneous body-weight fluctuation is uncommon in this population. This study aimed to identify key parameters—particularly the normal protein catabolic rate (nPCR)—that can guide dry weight (DW) adjustment in HD patients receiving tirzepatide.

Fields of Study & Subjects

Dialysis and Renal Disease Management Chronic Kidney Disease and Diabetes Heart Failure Treatment and Management

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104725–104725
Publication date
25 March 2026
Language
EN